Background: Randomized controlled trial (RCT) data on the response of serum total 25-hydroxyvitamin D [25(OH)D] in healthy participants consuming UV light-exposed edible mushrooms are limited and mixed.
Introduction
Vitamin D inadequacy, in terms of serum 25-hydroxyvitamin D [25(OH)D] 8 concentrations <50 nmol/L (1) and percentage of the population with daily intakes less than the Estimated Average Requirement (2) , is very common in Europe (3, 4) States (5) (6) (7) . Due to public health concerns associated with increased sunlight exposure, food-based solutions to raise the vitamin D nutritive status are being increasingly emphasized (8, 9) . Although there are relatively few foods naturally rich in vitamin D, adding vitamin D to foods, in the form of mandatory or voluntary fortification, has been shown to increase the populationÕs average intake of vitamin D (3, 6) and raise consumersÕ serum 25(OH)D concentrations (10, 11) . Vitamin D fortification of food has largely focused on additions to fluid milk and margarine and, to a lesser extent, to cheese, yogurt, orange juice, breakfast cereals, and other foods (10) , although it has been stressed that fortification and biofortification [sometimes referred to as bioaddition (12) ] strategies need to consider a range of foods to accommodate dietary diversity (13) . In this regard, UV light-exposed edible mushrooms are a novel, unappreciated, and unexploited food source offering a natural solution beyond traditional fortification to increase the vitamin D intake in the general population, particularly in those following vegetarian or vegan regimens.
Mushrooms are very rich in ergosterol, the principal sterol in fungi, and on exposure to wavelengths <315 nm (UV-C and UV-B) from the sun (14) or artificial lighting (15) , this provitamin D 2 compound is converted to ergocalciferol (vitamin D 2 ) in a process resembling the cutaneous synthesis of cholecalciferol (vitamin D 3 ) in humans. Although wild mushrooms can naturally contain high concentrations of vitamin D 2 (16, 17) , the vitamin D 2 content of cultivated mushrooms is minimal [<0.1 mg/100 g fresh weight (18) ] because they are cultivated indoors without the benefit of UV light. UV light thus offers the potential to enhance the vitamin D content of commercial mushrooms, and such vitamin D 2 -enriched mushrooms would not just be consumed as a food per se but could be freeze-dried and ground to a powder, usable in a variety of food products. UV-exposed mushrooms have been shown in long-term feeding trials in rodents to be safe and an effective source of vitamin D 2 , revealing benefits for bone and immune health (19, 20) . Randomized controlled trial (RCT) data on the response of serum 25(OH)D in healthy participants consuming UV-exposed (solar or artificial) edible mushrooms (generally Craterellus tubaeformis and Agaricus bisporus, respectively) have been mixed, with some showing clear improvements (21) (22) (23) (24) (25) and others little, if any, effect (26) (27) (28) . Moreover, data from 3 of the RCTs (25, 26, 28) suggest a differential effect of UV mushroomderived vitamin D 2 on serum 25-hydroxyergocalciferol [25(OH)D 2 ] and 25-hydroxycholecalciferol [25(OH)D 3 ] (increasing and decreasing, respectively), a phenomenon also reported in conjunction with vitamin D 2 supplements (29, 30) , with potential implications for the relative efficacy of vitamin D 2 in raising serum total 25(OH)D compared with vitamin D 3 .
The objective of the present work was to undertake a systematic review and meta-analysis in which we would access available RCT data reporting the response of serum total 25(OH)D [and serum 25(OH)D 2 and 25(OH)D 3 , if available] to the consumption of UV light-exposed edible mushrooms, as a source of additional vitamin D 2 , in healthy participants. To add to the limited published RCT data for inclusion in our meta-analysis, we also undertook an LC-MS/MS reanalysis of biobanked sera from our RCT of UV-exposed mushrooms (22) , in which total 25(OH)D was originally assessed by RIA and thus lacked information on serum 25(OH)D 2 or 25(OH)D 3 .
Methods
There were 2 component steps to our approach: we first reanalyzed stored sera from the RCT by Urbain et al. (22) in 2011 using LC-MS/MS so that we would obtain data on serum 25(OH)D 2 and 25(OH)D 3 , as well as for total 25(OH)D. Our systematic review revealed that this RCT was one of the only 6 RCTs available that met our inclusion criteria (see below), but because the original analysis of serum 25(OH)D values was by RIA, we could not delineate the effect of increased vitamin D 2 intake on serum 25(OH)D 2 and 25(OH)D 3 concentrations. These newly generated serum 25(OH)D data [i.e., total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 ] were then included in our meta-analysis of the effect of UV-exposed mushrooms on serum total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 using RCT data.
Reanalysis of stored sera from the Urbain et al. (22) RCT for total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 Full details on the RCT by Urbain et al. (22) have been described previously. In brief, and by way of context, in a 5-wk winter-based, single-blinded, randomized, placebo-controlled trial, 26 young adults with serum 25(OH)D #50 nmol/L were randomly assigned to 3 groups, which on 4 occasions at weekly intervals consumed 1) UV-exposed mushrooms (containing 491 mg vitamin D 2 /100 g fresh weight) and made into soup, 2) a vitamin D 2 supplement plus control mushroom soup, and 3) a placebo plus control mushroom soup. Biobanked sera from the study were retrieved from the 280°C freezer and shipped on dry ice to the Cork Centre for Vitamin D and Nutrition Research at University College Cork, Ireland, for reanalysis of total 25(OH)D [i.e., 25(OH)D 2 plus 25(OH)D 3 ] by an LC-MS/MS method that is traceable to the reference measurement procedures as described in detail elsewhere (31, 32) . The quality and accuracy of serum 25(OH)D analysis by the LC-MS/MS in our laboratory are monitored on an ongoing basis by participation in the Vitamin D External Quality Assessment Scheme (Charing Cross Hospital, London, United Kingdom). In addition, the Vitamin D Research Group is a participant in the Vitamin D Standardization Program (33) and is certified by the CDCÕs Vitamin D Standardization Certification Program (34) . In both human serum and plasma, 25(OH)D metabolites have been shown to be stable when stored frozen (35) and when subjected to multiple freeze-thaw cycles (36) . In addition, Hollis (37) has reported that long-term (>10-y) storage of pooled human 25(OH)D internal controls at 220°C led to no detectable degradation of 25(OH)D.
Statistical analysis of the Urbain et al. (22) RCT data based on reanalyzed serum 25(OH)D. Statistical analysis of the data was conducted using SPSS for Windows version 21.0 (SPSS, Inc.). The distributions of all variables were tested with Kolmogorov-Smirnov tests. Descriptive statistics (means 6 SDs) were determined for all variables. Paired t tests were used to compare mean baseline serum total 25(OH)D concentrations via original RIA analysis and LC-MS/MS reanalysis. Linear models of the response in a repeated-measures analysis for the differences in serum total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 concentrations were constructed. Treatment 3 time interactions were explored. One-factor ANOVA was used to test for between-group effects on serum total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 concentrations at each of the various time points, and TukeyÕs tests were used for post hoc analysis. Paired t tests were used to compare within-treatment group changes from baseline to week 4 (representing the intervention phase of the study; week 5 was a follow-up period). A P value of <0.05 was taken as being statistically significant.
Systematic review and meta-analysis of the effect of UV-irradiated mushrooms on serum total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 : RCT data We adhered to the guidance for systematic reviews on biomarkers of micronutrient status, which suggests the pooling should include >3 studies and >50 participants overall (38) . The method in the present work follows the general method for systematic reviews in the area of serum 25(OH)D as applied by us previously (10, 39, 40) , with brief specific details as follows.
Inclusion criteria. Studies were RCTs of UV-exposed mushrooms in apparently healthy humans, fulfilling all the following characteristics: 1) UV-irradiated mushrooms (as food per se or dried and powdered) consumed daily or once weekly; 2) reported circulating total 25(OH)D concentrations after supplementation in at least one intervention group and one control group (which received either non-UV-exposed mushrooms, as a control food, powder, or capsule, or no supplementation with vitamin D 2 or D 3 ); 3) no other supplemental nutrients (besides vitamin D 2 and natural nutrient content of mushrooms or mushroomcontaining foods/powders), hormones, or pharmaceutical agents coadministered; and 4) 3-wk minimum duration.
Search strategy and data collection. Electronic searches were run on Ovid MEDLINE, EMBASE (Ovid), and Cochrane CENTRAL from inception to 30 October 2015 by using a structured search strategy (see Supplemental Table 1 for full Ovid MEDLINE search strategy). Study selection was independently conducted by 2 authors (KMS and KDC), first by a screen of the titles and abstracts, followed by a review of the full text of potentially relevant studies. Information on the number of records identified, abstracts and full-text articles screened, and articles excluded and included in the qualitative and quantitative synthesis is provided in Figure 1 . Figure 1 of their article, but upon contact, the authors kindly provided the mean and SE data for inclusion in our metaanalysis. The data from the RCT by Outila et al. (21) had to be approximated from Figure 1 in their article because it did not provide the required data (the authors were contacted, but unfortunately after checking, they confirmed the data were unavailable due to the study being conducted >15 y ago).
In the one RCT (26) in which there were 2 UV mushroom intervention arms and one common control group, only the highest dose of UV mushrooms and the control arm were used for this analysis. Treatment effects were summarized as the mean difference with 95% CIs by using the absolute change values for control and treatment groups. Metaanalysis was carried out with Cochrane software, Review Manager version 5.2 (Cochrane Collaboration), with random-effects analysis to determine the overall weighted mean difference (WMD). In addition to forest plots, the presence of statistical heterogeneity was examined using the x 2 statistic with a P value <0.10 indicating significant heterogeneity. The I 2 statistic was also assessed: an I 2 of 0% indicated no heterogeneity, whereas 25%, 50%, and 75% were considered low, moderate, and high heterogeneity, respectively (41) . A subgroup analysis stratifying RCTs on the basis of latitude (study conducted at <45°N or $45°N) was planned a priori to explore potential differences in treatment effect between the studies, based on our previous work (10, 40) . Compared with participants in the European-based RCTs ($45°N), those in the RCTs conducted in the United States (i.e., <45°N) were likely to have a higher baseline serum total 25(OH)D due to greater UV-B availability and/or from vitamin D-fortified foods (1) .
An assessment of the risk of bias in the RCTs included in the metaanalysis was performed using the Cochrane CollaborationÕs tool for assessing risk of bias (42) .
Results
Reanalysis of stored sera from the Urbain et al. (22) RCT for total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 . The serum concentrations of total 25(OH)D, as measured via the original RIA analysis, and total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 after reanalysis of stored sera by LC-MS/MS for the 3 treatment groups [UV-exposed mushroom, vitamin D 2 supplement, and control (non-UV-exposed mushrooms)] are shown in Table 1 . Using the data from the LC-MS/MS reanalysis of stored sera, repeated-measures ANOVA showed that there was a significant time 3 treatment group interaction for serum total 25 (OH)D, 25(OH)D 2 , and 25(OH)D 3 (P < 0.0001 for all 3). Post hoc analysis showed that serum total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 changed over time in the UV-exposed mushroom and supplemental vitamin D 2 groups but not in the placebo group (Table 1 ). The mean serum total 25(OH)D concentration at baseline was significantly higher in the UV-exposed mushroom (22) with UVexposed mushrooms, vitamin D 2 supplements, or matching placebos (n = 26). Lines are the regression line (straight) with its 95% CIs (outer curved lines). The regression equation was as follows: D25hydroxycholecalciferol = 24.842 2 (0.201 Á D25-hydroxyergocalciferol) (R 2 = 0.44; P , 0.001).
UV mushrooms and serum 25(OH)D 567 group compared with the vitamin D 2 supplement or placebo groups (Table 1) . Therefore, adjusting for baseline concentrations in a univariate model, serum total 25(OH)D concentration at week 4 [after the intervention had ceased and before seasoninduced endogenous production of serum 25(OH)D 3 was evident] was significantly (P < 0.001) higher in the UV-exposed mushroom and vitamin D 2 supplement groups compared with the placebo group (adjusted mean 6 SD: 54.7 6 12.8 and 70.2 6 12.0 compared with 27.3 6 11.0 nmol/L, respectively), with that of the UV-exposed mushroom group significantly (P = 0.035) lower than that of the vitamin D 2 supplement group.
Post hoc analysis showed that the serum 25(OH)D 2 concentration rose over the intervention period in the UV-B-irradiated mushroom and supplemental vitamin D 2 groups, whereas the serum 25(OH)D 3 concentration dropped over the intervention period in the same 2 groups ( Table 1 ). The mean serum 25(OH)D 3 , but not 25(OH)D 2 , concentration at baseline was significantly higher in the UV-exposed mushroom group than in the vitamin D 2 supplement group, and the placebo group was similar to both ( Table 1) . Adjusting for baseline concentrations in a univariate model, the mean serum 25(OH)D 3 concentration at week 4 was significantly lower in the UV-exposed mushroom and vitamin D 2 supplement groups compared with the placebo group (adjusted mean 6 SD: 14.6 6 4.1 and 16.3 6 3.9 compared with 25.4 6 3.6 nmol/L, respectively), with no significant (P = 0.45) difference between the 2 vitamin D 2 treatment groups.
Using data from baseline to week 4, the mean nmol/L increase in serum 25(OH)D 2 and total 25(OH)D per mg additional vitamin D 2 consumed as UV-exposed mushrooms was 0.44 and 0.22 nmol/L Á mg/d, respectively. At the level of individual participants, the change in serum 25(OH)D 2 concentration from baseline to week 4 was used to predict the change in serum 25(OH)D 3 concentration over the same period ( Figure 2) . Linear regression analysis revealed a significant inverse association, with a 1-nmol/L increase in serum 25(OH)D 2 predicting a decrease in serum 25(OH)D 3 of 0.20 nmol/L ( Figure 2 ).
Systematic review and meta-analysis of the effect of UV-exposed mushrooms on serum total 25(OH)D, 25(OH)D 2 , and 25(OH)D 3 : RCT data. Our structured search yielded 8 studies (Figure 1 ), of which 5 were deemed suitable as meeting our inclusion criteria (21, 22, 25, 26, 28) . Two additional RCTs (24, 27) were identified by correspondence with collaborators and experts in the field, one of which was deemed suitable as meeting our inclusion criteria (27) . Of the 6 RCTs, all provided extractable data on serum total 25(OH)D concentration, whereas 4 provided extractable data on 25(OH)D 2 and 25(OH)D 3 concentrations [this increased to 5 when we included the data from LC-MS/MS reanalysis of stored sera from the Urbain et al. (22) RCT in the present work]. In the case of the 2 other RCTs identified, one was in prediabetic, overweight/obese adults (23) , and other was in healthy adults (24) , but neither RCT had an unexposed mushroom-fed group or group receiving no supplemental vitamin D 2 or D 3 needed to meet the study criteria of a control group. For this reason, neither study was included for the meta-analysis, but aspects of the findings were of value to the present work and are thus incorporated in our narrative (Figure 1 ). Details from the included studies are shown in Tables 2 and 3 . Of the 6 studies, 1 was conducted in females only (21), 2 were done with males only (25, 28) , and the other 3 were mixed. Five of 6 RCTs were of adults [one with car racing pit crew athletes (28) ] and 1 of teenage athletes (mean age: 16.2 y) (25) . Three RCTs included a vitamin D 2 supplementation group as well as a UV-exposed mushroom treatment group compared with a control group. The mean age and BMI of the study population or of the study groups are provided in Tables 2 and 3 , as is information on the season during which the RCT was conducted.
Within each of the 5 RCTs, serum total 25(OH)D concentrations were similar in the intervention and control arms at baseline [the sixth RCT (27) did not report the comparison], but among the RCTs, 2 studies (21, 22) had mean baseline concentrations in the range of 29-39 nmol/L (winter-based RCTs); 3 studies had ranges of 40-50 nmol/L (27) , 62-70 nmol/L (25) , and 91-102 nmol/L (28) (despite being winter-based RCTs); and another study (26) had mean baseline concentrations in the range of 71-102 nmol/L (summer and late-autumn RCT). In this RCT by Stephensen et al. (26) , participants were recruited in 4 cohorts spread across the relatively UV-B-rich part of the year, starting and finishing (n completing) as follows: June and July (n = 6) in cohort 1, July and August (n = 6) in cohort 2, August and October (n = 10) in cohort 3, and October and November (n = 13) in cohort 4. Within the 6 RCTs, the number of participants per study arm (7-24 participants) was relatively low, but the RCTs were nevertheless powered to detect significant differences stemming from the interventions. The studies were generally of relatively short duration (3-6 wk). A formal quality assessment scoring system (such as the Jadad scale) was not adopted in the present work, but all 6 RCTs reported verification of the vitamin D content of the UV mushroomcontaining food/supplement. Four did not report compliance (21, (25) (26) (27) , and one observed the consumption of the foods (22) . There was a relatively low percentage of participant dropouts (0-22% within a study arm) in these studies (21, 22, (25) (26) (27) (28) .
The summary assessments of risk of bias across domains and across the 6 RCTs are shown in Supplemental Table 2 . Most RCTs had a low risk of bias for selection bias, with one having high risk because of the open nature of the trial, but this was by design because it was focused on bioavailability of vitamin D 2 (21) . In relation to performance and detection bias, most RCTs also had a low risk of bias for blinding of participants and for blinding of outcome assessment, but risk of bias was unclear for blinding of personnel. In relation to attrition bias, risk of bias in relation to incomplete outcome data was low for 3 RCTs and unclear for the remaining 3. Risk of bias for selective reporting was low in 5 RCTs, with unclear risk in 1 RCT (27) because the authors did not report the comparison of serum total 25(OH)D concentrations in the intervention compared with control arms at baseline. Overall, most of the information used in the present meta-analysis is from studies at low or unclear risk of bias. Age is reported as a range when the mean 6 SD was unavailable. 3 BMI is reported as a range when the mean 6 SD for entire study group was unavailable. 4 Analytical methods for analyzing circulating 25(OH)D levels. Table  4 , and this either only minimally reduced or reduced the level of heterogeneity. Including only the 3 RCTs conducted in European locations ($45°N; mean baseline serum 25(OH)D: 38.6 nmol/L), serum total 25(OH)D increased significantly by UV-exposed mushroom consumption (random effect WMD: 15.2 nmol/L; P < 0.03; see Table 4 ), but the analysis showed a high degree of heterogeneity (I 2 = 88%). Limiting the analysis to the 2 European RCTs (21, 22) with the lowest baseline serum 25(OH)D (i.e., <40 nmol/L) showed that serum total 25(OH)D rose even more significantly via UV-exposed mushroom consumption (random effect WMD: 22.3 nmol/L; 95% CI: 16.4, 28.2 nmol/L; P < 0.00001; 2 studies, 35 participants), and importantly, the level of heterogeneity was much reduced (I 2 = 33%) (data not shown).
Including only the 3 RCTs conducted in the US locations [i.e., <45°N; mean baseline serum 25(OH)D: 81.5 nmol/L], serum total 25(OH)D was not significantly increased by UV-exposed mushroom consumption (random effect WMD: 1.5 nmol/L; P = 0.83; see Table 4 ), but the analysis showed a high degree of heterogeneity (I 2 = 69%).
Data from the recent RCT in prediabetic, overweight/obese adults by Mehrotra et al. (23) suggest that UV-exposed mushrooms increased total 25(OH)D [and serum 25(OH)D 2 ] over 4 mo (most participants receiving the intervention in winter in New York) but only when the mushrooms contained an equivalent of 65.2 mg vitamin D 2 /100 g (after processing) and not a lower dose of 12.1 mg vitamin D 2 /100 g. Data from the RCT in healthy adults by Keegan et al. (24) suggest that UV-exposed mushrooms that were extracted and included in a capsule (containing 50 mg vitamin D 2 /d) increased total 25(OH)D and serum 25(OH)D 2 over 12 wk (time of year not stated).
Unfortunately, the lack of an unexposed mushroom-fed group or group receiving no supplemental vitamin D 2 or D 3 intervention needed to meet with the study criteria of a control group in both RCTs prevented us from including these data in our metaanalysis.
Serum 25(OH)D 2 and 25(OH)D 3 response. The analysis of serum 25(OH)D 2 was also highly heterogeneous (I 2 = 99%), but all point estimates from the 5 RCTs showed a statistically significant effect of supplementation with UV-exposed mushrooms on circulating serum 25(OH)D 2 , and the analysis was significant overall (P = 0.001) (Supplemental Figure 2A) . The analysis of serum 25(OH)D 3 (again from 5 RCTs) revealed a statistically significant (P < 0.00001) decline in serum 25(OH)D 3 upon supplementation with UV-exposed mushrooms (random effect WMD: 213.3 nmol/L; Supplemental Figure 2B ), and this analysis had no heterogeneity (I 2 = 0%).
The data from the RCT in prediabetic, overweight/obese adults by Mehrotra et al. (23) suggest that mushrooms exposed to a higher UV dose (equivalent of 65.2 mg vitamin D 2 /100 g after processing), although increasing serum 25(OH)D 2 and total 25(OH)D over 4 mo, did not significantly reduce serum 25(OH)D 3 (36.2 nmol/L at baseline and 31.2 nmol/L after 4 mo). Again, their lack of an unexposed mushroom-fed group or group receiving no supplemental vitamin D 2 or D 3 intervention needed to meet with the study criteria of a control group limits the possibility of us including these data in our meta-analysis.
Discussion
Despite growing interest in the use of UV-exposed mushrooms as a source of enhanced dietary supply of vitamin D (23, 24) , the number of RCTs evaluating their effectiveness in terms of raising serum total 25(OH)D [a robust and reliable marker of vitamin D status (39) ] is relatively few, and their findings are mixed. Accordingly, we wished to apply a meta-analysis approach to these mixed RCT data. Including the data from 6 RCTs, identified as meeting the criteria for inclusion in our systematic review and meta-analysis, seemed to suggest a nonsignificant increase in serum total 25(OH)D (WMD = 8.6 nmol/L over the control group) but with a very high degree of heterogeneity in the analysis. The high degree of heterogeneity is a limitation in the present analysis, and although there are several underpinning potential reasons, including differences in vitamin D 2 dose provided in the form of UV mushrooms, format of their preparation, differences in age groups, and 25(OH)D analytical technique, one of key differences in the collection of studies is Including data from all 6 RCTs (21, 22, (25) (26) (27) (28) and, in the case of the RCT by Urbain et al. (22) , values from LC-MS/MS reanalysis of stored sera included. 3 Three RCTs conducted in United States (25, 26, 28) . 4 Three RCTs conducted in Europe (21, 22, 27) .
baseline serum total 25(OH)D due to differences in UV-B availability and/or vitamin D intake from vitamin D-fortified foods. As the baseline vitamin D status in the US-based studies (25, 26, 28) was much higher than that in the 3 European-based RCTs (21, 22, 27) , we performed a subgroup analysis including only the European-based RCTs (at latitudes >45°N). Although this analysis also revealed a high degree of heterogeneity (I 2 = 88%), we detected an even greater and significant increase in serum total 25(OH)D with consumption of UV-exposed mushrooms (WMD = 15.2 nmol/L). Of note, although the RCT by Stepien et al. (27) was based in winter, the baseline mean serum 25(OH)D concentration of its participants was higher than in the other 2 winter-based RCTs (range: 40-50 nmol/L compared with 29-39 nmol/L, respectively). This was the only RCT with an unclear risk of outcome reporting bias, which may be one of the most substantial biases affecting results from individual studies. Omitting the RCT by Stepien et al. (27) in a further subanalysis led to a much lower level of heterogeneity in the analysis (I 2 = 33%) and overall to an even greater increase in serum total 25(OH)D (WMD = 22.3 nmol/L; P < 0.00001). The notion that baseline serum 25(OH)D concentration may affect the response of vitamin D status to UV-exposed mushroom consumption was further supported by the subanalysis using the 3 US-based RCTs, which collectively showed a lack of effect (P = 0.83), although the analysis was subject to a high degree of heterogeneity. Only 1 of the 3 RCTs individually showed a significant increase in serum total 25(OH)D concentration upon consumption of UV-exposed mushrooms (25) , and the baseline mean serum 25(OH)D concentration of its participants was lower than in the other 2 RCTs (range: 62-70 nmol/L compared with 71-102 nmol/L, respectively). Interestingly, the 2 additional RCTs that did not satisfy our inclusion criteria but reported significant increases in serum total 25(OH)D and 25(OH)D 2 with consumption of UV-exposed mushrooms (supplying >2000 IU vitamin D 2 /d) were also conducted in the United States and reported mean baseline serum total 25(OH)D concentrations of 42.5 nmol/L (23) and 51.5 nmol/L (24), respectively.
The data on serum 25(OH)D 2 and 25(OH)D 3 separately, which were available for 5 of the 6 RCTs, were useful in explaining the findings in relation to serum total 25(OH)D. The meta-analysis showed that consumption of UV-exposed mushrooms overall led to a significant increase in serum 25(OH)D 2 , albeit with a very high degree of heterogeneity in the analysis. This may be consistent with the suggestion that vitamin D 2 in UV-exposed mushrooms is bioavailable (21) , but there was some suggestion from the present meta-analysis that the additional vitamin D 2 in the UV-exposed mushrooms used in some of the RCTs may not have been as bioavailable as vitamin D 2 from supplements (22, 26) . For example, data from the reanalyzed sera in the RCT by Urbain et al. (22) showed that the response of serum 25(OH)D 2 over 4 wk to additional vitamin D 2 from the UV mushrooms was less (223%) than that from the equivalent amount of supplemental vitamin D 2 . To counteract the issue of different doses of additional vitamin D 2 achieved by mushrooms exposed to a higher UV dose and vitamin D 2 supplementation groups (17.1 and 28.2 mg/d, respectively), Stephensen et al. (26) reported the change in serum 25(OH)D 2 over the 6-wk study period divided by the median intake of vitamin D 2 , finding it was less in the mushroom group than in the vitamin D 2 supplementation group. The other 4 RCTs either did not provide serum 25(OH)D 2 data (21) or had a vitamin D 2 supplement group (25, 27, 28) .
Of note, when serum 25(OH)D 3 data from the same 5 RCTs were used, the meta-analysis revealed an overall reduction in serum 25(OH)D 3 in conjunction with consuming additional vitamin D 2 in the form of UV-exposed mushrooms. This metaanalysis data on vitamin D 2 from a food matrix agree with the data from some RCTs addressing vitamin D 2 supplementation/ fortification that suggest a decrease in serum 25(OH)D 3 (29, 30) , which may account for the 30% lower response of vitamin D 2 in raising total 25(OH)D compared with vitamin D 3 (29) , although other RCTs did not identify this effect (43) (44) (45) (46) .
Houghton and Vieth (47) provide a very succinct overview of several biologically plausible mechanisms that could contribute to the lesser capacity of vitamin D 2 over D 3 to maintain higher circulating 25(OH)D concentrations over time. These include potentially higher affinities of vitamin D 3 and its metabolites than vitamin D 2 for hepatic 25-hydroxylase, vitamin D-binding protein, and vitamin D receptor and because vitamin D 3 is not directly metabolized to 24(OH)D as is vitamin D 2 (47) . However, it is not clear whether these fully explain the observed decrease in serum 25(OH)D 3 with increasing vitamin D 2 in the present meta-analysis. Stephensen et al. (26) reported no significant difference in serum 24,25-dihydroxyvitamin D 3 concentrations over the 6-wk study period between any of the 3 vitamin D 2 treatment groups and a control (receiving no vitamin D 2 ), suggesting increased catabolism is not the mode by which consumption of UV-exposed mushrooms led to reduced circulating 25(OH)D 3 concentrations. An alternative possibility is that there was preferential 25-hydroxylation of vitamin D 2 upon increased intake of this vitamer (48) or that the increased vitamin D 2 intake may simply dilute vitamin D 3 at serum 25(OH)D and 1,25-dihydroxyvitamin D concentrations (49) .
In light of the serum 25(OH)D 3 findings, even if the mechanisms of action are not fully delineated, it is tempting to suggest that the lack of effect in 2 of the 3 US-based studies may have been due to their much higher baseline serum total 25(OH) D (mean >71 nmol/L), which would have provided more serum 25(OH)D 3 to compete with 25(OH)D 2 and resulted in almost equal amounts of the 2 metabolites being decreased and increased, respectively, on consuming UV mushrooms (26, 28) and overall no net change in serum total 25(OH)D. In difference, the amount of baseline 25(OH)D 3 was lower in the third US-based RCT (25) and the European-based studies, due to lower status in winter >45°N, and the reported decrease in serum 25(OH)D 3 per increment in serum 25(OH)D 2 in the UV mushroom-treated groups was much lower [0.2-to 0.7-nmol/L decrease per 1-nmol/L increase in serum 25(OH)D 2 ] (22, 25), with overall net increases in serum total 25(OH)D. However, the RCT by Stepien et al. (27) did not find an effect of UV-exposed mushrooms on serum total 25(OH)D or 25(OH)D 3 . Thus, other study design variables may have also played a part in the observed differences and may explain some of the divergent findings among the RCTs. The impact of the dose of vitamin D 2 supplied by the UV-exposed mushrooms on the response of serum total 25(OH)D is not clear, because studies both reporting a significant increase (21) (22) (23) (24) (25) and not doing so (23, (26) (27) (28) had vitamin D 2 intakes spanning a range of ;10/15 to ;95/100 mg/d (thus ranging from approximately RDA to Tolerable Upper Intake values for vitamin D) (1, 50) . It could possibly relate to the way the UV mushrooms were processed and/or cooked in the various studies, which in turn may have affected vitamin D 2 bioavailability. Mushroom preparation ranged from lyophilization and homogenization and then included uncooked in broth (21) or in a sachet to be consumed mixed with any meal (25, 27, 28) , diced and used in a pureed mushroom soup and stored at 220°C (22), or microwaved and mixed with soybean oil in cooked entrées (26) . Mehrotra et al. (23) reported appreciable losses in the vitamin D 2 content of fresh raw mushrooms when they had been subjected to what the authors considered common methods of household meal preparation (i.e., cooked entrée with 100 g mushrooms and meals flash-frozen, stored frozen, thawed, and reheated in a microwave before consumption).
In conclusion, cognizant of the heterogeneity in the analysis, taken collectively, data from those RCTs with UV-exposed and vitamin D 2 -enriched mushrooms included in our meta-analysis, together with the 2 additional RCTs that did not satisfy our inclusion criteria, might suggest an effect on serum total 25(OH)D when the mean baseline vitamin D status of the participants is inadequate [serum 25(OH)D less than ;50 nmol/L], but no effect when vitamin D status is high, which seems due to a reduction in serum 25(OH)D 3 that accompanies the increase in 25(OH)D 2 . This should ideally be tested in an appropriately designed RCT where participants are stratified by baseline vitamin D status. Further research is also needed to explore whether the observed UV-exposed mushroom-induced reduction in serum 25(OH)D 3 concentrations, even in studies where total 25(OH)D increased, has any physiologic importance.
